Search Results - Graham P. Collins

Refine Results
  1. 1

    Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in... by Toby A. Eyre, Faouzi Djebbari, Amy A. Kirkwood, Graham P. Collins

    Published in Haematologica (2020-07-01)
    Get full text
    Article


  2. 2

    Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients by Kamel Ait-Tahar, Amanda P. Anderson, Martin Barnardo, Graham P. Collins, Chris S. R. Hatton, Alison H. Banham, Karen Pulford

    Published in Advances in Hematology (2017-01-01)
    Get full text
    Article


  3. 3

    Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens. by Christopher D O Cooper, Charles H Lawrie, Amanda P Liggins, Graham P Collins, Christian S R Hatton, Karen Pulford, Alison H Banham

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  4. 4

    Examining the levels of psychological support available to patients with haematological cancer in England: a mixed methods study by Eila Watson, Catherine Henshall, Jo Brett, Kate Robinson, Anke Ehlers, Paul Dawson, Graham P Collins, Tracy Mitchell-Floyd, Anya Aspinall, Catriona Gilmour-Hamilton

    Published in BMJ Open (2023-02-01)
    Get full text
    Article


  5. 5

    PB2296: ROBUST BRUTON’S TYROSINE KINASE (BTK) DEGRADATION WITH NX-5948, AN ORAL BTK DEGRADER, IN A FIRST-IN-HUMAN PHASE 1A TRIAL IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY B CELL M... by Kim Linton, Francesco Forconi, David Lewis, John Riches, Dima El-Sharkawi, Mary Gleeson, Sarah G Injac, Srinand Nandakumar, May Tan, Ganesh Cherala, Graham P Collins

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  6. 6

    Adult T cell leukaemia/lymphoma (ATL) in pregnancy: A UK case series by Leila Motedayen Aval, Mary Boullier, Hermione Lyall, Graham P. Collins, Robert Ayto, Dominic F. Kelly, Richard S. Tedder, Simon B. Drysdale, Graham P. Taylor, Lucy B. Cook

    Published in eJHaem (2021-02-01)
    Get full text
    Article


  7. 7

    PB2331: AN ONGOING FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-5948, AN ORAL BRUTON’S TYROSINE KINASE (BTK) DEGRADER, IN PATIENTS WITH RELAPSED/REFRACTORY B CELL MALIGNANCIES by Kim Linton, Jeanette Doorduijn, Dima El-Sharkawi, Rogier Mous, Francesco Forconi, David Lewis, Mary Gleeson, John Riches, Pam Mckay, Wendy Stevens, Sarah G Injac, Graham P Collins

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  8. 8

    Working towards harmonization of clinical trial reporting in Hodgkin lymphoma by Carsten Kobe, Philippe Armand, Sven Borchmann, Graham P. Collins, Anne‐Segolene Cottereau, Justin Ferdinandus, Alex F. Herrera, Davide Rossi, Wouter J. Plattel, Sally F. Barrington, Martin Hutchings

    Published in HemaSphere (2025-08-01)
    Get full text
    Article


  9. 9

    CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma by Kamel Ait-Tahar, Amanda P. Liggins, Graham P. Collins, Andrew Campbell, Martin Barnardo, Maite Cabes, Charles H. Lawrie, Donald Moir, Chris Hatton, Alison H. Banham, Karen Pulford

    Published in Haematologica (2011-01-01)
    Get full text
    Article


  10. 10

    Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy by Toby A. Eyre, Harriet S. Walter, Sunil Iyengar, George Follows, Matthew Cross, Christopher P. Fox, Andrew Hodson, Josh Coats, Santosh Narat, Nick Morley, Martin J.S. Dyer, Graham P. Collins

    Published in Haematologica (2019-02-01)
    Get full text
    Article


  11. 11

    Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1 by Howland E. Crosswell, Ann S. LaCasce, Nancy L. Bartlett, David J. Straus, Kerry J. Savage, Pier Luigi Zinzani, Graham P. Collins, Michelle Fanale, Keenan Fenton, Cassie Dong, Harry Miao, Andrew P. Grigg

    Published in Haematologica (2023-10-01)
    Get full text
    Article


  12. 12

    Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study by Michael Wang, Radhakrishnan Ramchandren, Robert Chen, Lionel Karlin, Geoffrey Chong, Wojciech Jurczak, Ka Lung Wu, Mark Bishton, Graham P. Collins, Paul Eliadis, Frédéric Peyrade, Yihua Lee, Karl Eckert, Jutta K. Neuenburg, Constantine S. Tam

    Published in Journal of Hematology & Oncology (2021-10-01)
    Get full text
    Article


  13. 13

    Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study by Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K. Fielding, Daniel M. Jennings, Marina Karakantza, Saad Al-Ismail, Graham P. Collins, Stewart McConnell, Catherine Langton, Magda J. Al-Obaidi, Metod Oblak, Sam Salek

    Published in Frontiers in Pharmacology (2020-09-01)
    Get full text
    Article


  14. 14

    Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO by Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K. Fielding, Daniel M. Jennings, Marina Karakantza, Saad Al-Ismail, Graham P. Collins, Stewart McConnell, Catherine Langton, Magda J. Al-Obaidi, Metod Oblak, Sam Salek

    Published in Frontiers in Pharmacology (2020-10-01)
    Get full text
    Article


  15. 15

    Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow‐up by Dennis A. Eichenauer, Marc André, Peter Borchmann, Graham P. Collins, Ian Doherty, Hans‐Theodor Eich, Massimo Federico, Alexander Fossa, Sylvia Hartmann, Martin Hutchings, Timothy Illidge, Carsten Kobe, Wouter J. Plattel, Lena Specht, Anna Sureda, Jan M. Zaucha, Joseé M. Zijlstra, Igor Aurer

    Published in HemaSphere (2026-06-01)
    Get full text
    Article


  16. 16

    The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study by Andrew D. Zelenetz, Wojciech Jurczak, Vincent Ribrag, Kim Linton, Graham P. Collins, Javier L. Jiménez, Mark Bishton, Bhagirathbhai Dholaria, Andrea Mengarelli, Tycel J. Phillips, Nagendraprasad Sungala, Gerardo Musuraca, Oonagh Sheehy, Eric Van Den Neste, Mitsuhiko Odera, Lu Miao, Daniel P. Gold, Richard G. Ghalie, Pier L. Zinzani

    Published in HemaSphere (2024-08-01)
    Get full text
    Article


  17. 17

    A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma by Graham P. Collins, Toby A. Eyre, Debora Schmitz-Rohmer, William Townsend, Rakesh Popat, Lisa Giulino-Roth, Paul A. Fields, Fatime Krasniqi, Carole Soussain, Anastasios Stathis, Nebojsa Andjelkovic, David Cunningham, Danijela Mandic, Sinisa Radulovic, Ivan Tijanic, Netanel A. Horowitz, Sabira Kurtovic, Elisabeth Schorb, Christian Schmidt, Saša Dimitrijević, Martin Dreyling

    Published in HemaSphere (2021-11-01)
    Get full text
    Article


  18. 18

    P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untre... by John Radford, Toyin Adedayo, Arzhang Ardavan, Sally F. Barrington, Leanne Berkahn, Stephane Chauvie, Laura Clifton-Hadley, Graham P. Collins, Michael Crump, David Cutter, Darren Edwards, Martin Hutchings, Tim Illidge, Amy A. Kirkwood, Kim Linton, Craig H. Moskowitz, Pip Patrick, Beth Phillips, Lois Shepherd, Sanne Tonino, Judith Trotman, Joanna Williams, Nicole Wong Doo

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  19. 19

    Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real‐world intention‐to‐treat analysis by Maeve A. O'Reilly, William Wilson, David Burns, Andrea Kuhnl, Frances Seymour, Ben Uttenthal, Caroline Besley, Rajesh Alajangi, Thomas Creasey, Shankara Paneesha, Johnathon Elliot, Carlos Gonzalez Arias, Sunil Iyengar, Matthew R. Wilson, Alison Delaney, Lourdes Rubio, Jonathan Lambert, Khalil Begg, Stephen Boyle, Kathleen P. L. Cheok, Graham P. Collins, Claire Roddie, Rod Johnson, Robin Sanderson

    Published in HemaSphere (2024-06-01)
    Get full text
    Article


  20. 20

    P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity by Anna Santarsieri, Katherine Sturgess, Pauline Brice, Tobias F. Menne, Wendy Osborne, Thomas Creasey, Kirit M. Ardeshna, Sarah Behan, Kaljit Bhuller, Stephen Booth, Nikesh Chavda, Graham P. Collins, Dominic Culligan, Kate Cwynarski, Andrew Davies, David Dutton, Michelle Furtado, Eve Gallop-Evans, Andrew Hodson, David Hopkins, Hannah Hsu, Sunil Iyengar, Stephen G. Jones, Kim Linton, Oliver Lomas, Nicolas Martinez-Calle, Abhinav Mathur, Pamela Mckay, Sateesh K. Nagumantry, Deidre O’Mahony, Beth Phillips, Neil Phillips, John F. Rudge, Nimish Shah, Gwyneth Stafford, Alex Sternberg, Rachel Trickey, Benjamin J. Uttenthal, Natasha Wetherall, Andrew K. Mcmillan, George A. Follows

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


Search Tools: